An, Q., Wang, H., Zhu, H., Jia, Y., Liu, Y., Liu, Z., . . . Zhou, Z. (2025, July). Nomogram-based risk stratification to analyze the value of receiving postoperative adjuvant therapy after neoadjuvant immunochemotherapy for patients with locally advanced esophageal squamous carcinoma. Frontiers in Immunology.
Chicago Style (17th ed.) CitationAn, Qiuying, et al. "Nomogram-based Risk Stratification to Analyze the Value of Receiving Postoperative Adjuvant Therapy After Neoadjuvant Immunochemotherapy for Patients with Locally Advanced Esophageal Squamous Carcinoma." Frontiers in Immunology Jul. 2025.
MLA引文An, Qiuying, et al. "Nomogram-based Risk Stratification to Analyze the Value of Receiving Postoperative Adjuvant Therapy After Neoadjuvant Immunochemotherapy for Patients with Locally Advanced Esophageal Squamous Carcinoma." Frontiers in Immunology, Jul. 2025.
